Eric Collins is currently the Cell and Gene Therapy Lead at Catalent Pharma Solutions, a position they have held since 2025. Previously, they served as the Cell and Gene Therapy Senior Manufacturing Lead at Theragent Inc from 2022 to 2025, and they held various roles in manufacturing at companies including Kite Pharma, BD Biosciences, and Sangart. Eric began their career as a Manufacturing Tech 2 at Advance Tissue from 1998 to 2004.
This person is not in any teams
This person is not in any offices